EcoDrugPlus

Kinesin Family Member 5b

Ensembl ID : ENSNBRG00000022547
Gene Symbol: KIF5B
2 Cross references
236 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSNBRG00000012740
Gene Symbol: KIF5B
4 Cross references
234 Possible Orthologues:

Leukotriene A-4 Hydrolase-Like

Ensembl ID : ENSNBRG00000018778
Gene Symbol: LOC102792121
3 Cross references
203 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSNBRG00000015962
Gene Symbol: LOC102793661
3 Cross references
157 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSNBRG00000005428
Gene Symbol: LOC102793433
3 Cross references
142 Possible Orthologues:

Leukotriene B4 Receptor 2b

Ensembl ID : ENSNBRG00000016043
Gene Symbol: LTB4R2B
1 Cross references
154 Possible Orthologues:

Leukotriene B4 Receptor 2b

Ensembl ID : ENSNBRG00000016108
Gene Symbol: LTB4R2B
1 Cross references
158 Possible Orthologues:

Lysine-Specific Histone Demethylase 1a-Like

Ensembl ID : ENSNBRG00000023869
Gene Symbol: LOC102778738
3 Cross references
212 Possible Orthologues:

Lysyl Oxidase Homolog 2a-Like

Ensembl ID : ENSNBRG00000016939
Gene Symbol: LOC102776160
3 Cross references
209 Possible Orthologues:

Lysyl Oxidase-Like 2b

Ensembl ID : ENSNBRG00000011908
Gene Symbol: LOXL2B
1 Cross references
213 Possible Orthologues:

Macrophage Colony-Stimulating Factor 1 Receptor 1-Like

Ensembl ID : ENSNBRG00000010188
Gene Symbol: LOC102793887
3 Cross references
63 Possible Orthologues:

Macrophage Colony-Stimulating Factor 1 Receptor 2-Like

Ensembl ID : ENSNBRG00000023315
Gene Symbol: LOC102779147
2 Cross references
204 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).